Nirsevimab for Prevention of RSV Hospitalizations in Infants. Reply

N Engl J Med. 2024 Mar 21;390(12):1152-1153. doi: 10.1056/NEJMc2400983.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Hospitalization*
  • Humans
  • Infant

Substances

  • nirsevimab
  • Antibodies, Monoclonal, Humanized